Huh, K.-Y.; Hwang, S.-j.; Park, S.-Y.; Lim, H.-J.; Jin, M.-y.; Oh, J.-s.; Yu, K.-S.; Chung, J.-Y.
Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib. Pharmaceutics 2021, 13, 629.
https://doi.org/10.3390/pharmaceutics13050629
AMA Style
Huh K-Y, Hwang S-j, Park S-Y, Lim H-J, Jin M-y, Oh J-s, Yu K-S, Chung J-Y.
Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib. Pharmaceutics. 2021; 13(5):629.
https://doi.org/10.3390/pharmaceutics13050629
Chicago/Turabian Style
Huh, Ki-Young, Se-jung Hwang, Sang-Yeob Park, Hye-Jung Lim, Mir-yung Jin, Jae-seong Oh, Kyung-Sang Yu, and Jae-Yong Chung.
2021. "Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib" Pharmaceutics 13, no. 5: 629.
https://doi.org/10.3390/pharmaceutics13050629
APA Style
Huh, K.-Y., Hwang, S.-j., Park, S.-Y., Lim, H.-J., Jin, M.-y., Oh, J.-s., Yu, K.-S., & Chung, J.-Y.
(2021). Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib. Pharmaceutics, 13(5), 629.
https://doi.org/10.3390/pharmaceutics13050629